Latest market price
14.46
-1.31-8.31%
GENBQT41Generate Biomedicines, Inc.·NASDAQ
14.46-8.31%

Latest SEC Filings

Form category
DescriptionFilingDocument
Sep 03, 20264Statement of changes in beneficial ownership
Sep 02, 2026144Notice of proposed sale of restricted securities
Sep 01, 2026144Notice of proposed sale of restricted securities
Aug 26, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
Mar 12, 20263Initial statement of beneficial ownership
Mar 06, 20264Statement of changes in beneficial ownership
Mar 02, 20264Statement of changes in beneficial ownership
Mar 02, 20264Statement of changes in beneficial ownership
Mar 02, 20264Statement of changes in beneficial ownership
Mar 02, 20264Statement of changes in beneficial ownership
Mar 02, 20264Statement of changes in beneficial ownership
Mar 02, 20264Statement of changes in beneficial ownership
Mar 02, 20264Statement of changes in beneficial ownership
Mar 02, 20264Statement of changes in beneficial ownership
Mar 02, 20268-KCurrent report
Mar 02, 20264Statement of changes in beneficial ownership
Mar 02, 20264Statement of changes in beneficial ownership
Mar 02, 20264Statement of changes in beneficial ownership
Mar 02, 20264Statement of changes in beneficial ownership